Bristol Myers Squibb signals beyond the news: 77+ signals from 8 sources
The latest Bristol Myers Squibb signal on this page is from Nov 17, 2026 (Patents): "Bristol-Myers Squibb was granted a patent for WEE1-degrading cancer compounds." The busiest sources: Glassdoor (15+), LinkedIn (15+) and Website changes (15+).
Get Bristol Myers Squibb's live signals in Claude or ChatGPT, or by API
What changed at Bristol Myers Squibb this week? Use Autobound signals for bms.com.- Signals
- 77+
- Sources
- 8
- Last 90 days
- 46
- Latest
- Nov 17, 2026
Source: Autobound Signal API · 118 signals tracked for Bristol Myers Squibb · updated
Other signals · latest 10
Latest Bristol Myers Squibb signals by source
77+ signals for Bristol Myers Squibb across 8 sources.
Patents · Patent grant
Bristol-Myers Squibb was granted a patent for WEE1-degrading cancer compounds
In November 2026 Bristol-Myers Squibb patented drug compounds designed for treating WEE1-related diseases, including cancer, in pharmaceutical and clinical settings.
- Patent title
- WEE1 degrading compounds and uses thereof
- Grant date
- Nov 17, 2026
- Inventors
- John Sapienza, Jennifer R. Riggs, Jacob T. Edwards, Daniel K. Cashion
Patents · Patent grant
Bristol-Myers Squibb was granted a patent for crystalline drug forms.
In November 2026 Bristol-Myers Squibb patented salt and crystal forms of a small-molecule compound for pharmaceutical development and medicine manufacturing.
- Patent title
- 2-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-indol-5-yl)piperidin-1-yl)acetamide salt and crystalline forms thereof
- Grant date
- Nov 17, 2026
- Inventors
- Prashant Mrityunjaya Sujata Kameshwar, Roopa Narasimhamurthy, Jennifer Nelson
Web traffic · Traffic snapshot
bms.com received 1M monthly visits with traffic from 5 countries.
- Monthly visits
- 1,070,767
- Month over month
- +0.1%
- 3-month change
- +4.8%
- Global rank
- 43,808
Reddit · Leadership change
Bristol Myers Squibb's head of R&D is departing the company amid an ongoing organizational restructure.
Post: "BMS R&D head to depart amid restructure"
- Subreddit
- r/biotech
- Upvotes
- 59
- Comments
- 18
- Sentiment
- Negative
X (Twitter)
Bristol-Myers Squibb merges Research and Drug Development into one organization led by Cristian Massacesi effective Jan. 1, 2027.
We’re bringing Research & Drug Development together as one organization, led by Cristian Massacesi, effective Jan. 1, 2027. This new structure will strengthen our focus on advancing science and delivering for patients. https://t.co/yb9U9K9Z8y #OneBMS https://t.co/kGs8dPGOz7
- Account
- @bmsnews
- Views
- 1,212
- Likes
- 10
- Reposts
- 0
Glassdoor · Layoff mentions
Recent reviews identify significant redundancies and cold management response to staff cuts
One employee reports frequent redundancies and describes higher management as cold, lacking empathy toward those impacted by staff reductions. This pattern suggests potential sensitivity around organizational restructuring and workforce planning.
- Overall rating
- 3.7 of 5
- CEO approval
- 67%
- Reviews read
- 10
- Review window
- Nov 1, 2026 to Nov 10, 2026
Website changes · Marketing content
BMS added prominent homepage features for its Survivorship Today initiative and Global Patient Week program.
Added links labeled “Featured initiatives” for “Survivorship Today” and “Global Patient Week.”
- Page
- /life-and-science.html
Podcasts · Sponsorship
Bristol Myers Squibb sponsors Tales from the Heart
Ask your healthcare provider about the latest FDA-approved treatment, Mycorzo, Afacampin. A once-daily pill for adults with symptomatic OHCM to improve functional capacity and symptoms... Learn more at MyCorso.com or call 1-833-697-8796.
- Podcast
- Tales from the Heart
- Episode
- A New HCM Treatment Takes Shape
Web traffic · Sustained growth
bms.com shows sustained growth with 3 consecutive months of increases, up 21% overall to 1M.
Minimal AI traffic at 0.8% (~9,061 visits). Top: chatgpt.com (82%), gemini.google.com (18%).
- Monthly visits
- 1,099,815
- Month over month
- +7.6%
- 3-month change
- +20.8%
- Global rank
- 37,842
LinkedIn
Wishing everyone a happy and healthy New Year!
Wishing everyone a happy and healthy New Year! Here’s to building on what we’ve learned and delivering meaningful progress for patients around the world in 2026. #OneBMS
- Likes
- 922
- Comments
- 14
- Tags
- Patient Experience, Medical Research, Corporate Strategy
Showing 10 of 77+ signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Bristol Myers Squibb with the Signal API
One POST /v1/companies/enrich call with bms.com returns Bristol Myers Squibb signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "bms.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Bulk data
Need these signals for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file).
Same industry
Other signals at related companies
Questions about Bristol Myers Squibb other signals
What signals does Autobound track for Bristol Myers Squibb besides news and filings?
What are people saying about Bristol Myers Squibb online?
What do employees say about working at Bristol Myers Squibb?
Has Bristol Myers Squibb been granted patents recently?
Page updated , the date of the newest row on this page.
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .